
Broward Weight Loss and Primary Care operates as a telehealth-focused medical practice in Lauderhill, Florida, specializing in medication-assisted weight management for patients across the state. The clinic's approach centers on evidence-based pharmacotherapy using GLP-1 receptor agonists and dual-incretin therapies, with prescribing protocols tailored to individual metabolic profiles and weight loss goals. By offering remote consultations, the practice eliminates geographic barriers for Florida residents seeking medical supervision for chronic weight management without requiring in-person office visits.
Broward Weight Loss and Primary Care's peptide therapy menu includes Liraglutide, and Semaglutide, with treatment protocols customized based on individual health goals and lab work. Additional peptide options may be available based on medical necessity and FDA guidelines.
The medical team at Broward Weight Loss and Primary Care consists of licensed Florida physicians who conduct comprehensive intake assessments via HIPAA-compliant video platforms. Initial consultations include review of weight history, previous diet and exercise attempts, current medications, laboratory values, and realistic goal-setting discussions. Providers explain the mechanism of action for each peptide option—how these medications slow gastric emptying, reduce appetite through hypothalamic signaling, and improve glycemic control—allowing patients to make informed decisions about their treatment path. Follow-up appointments occur monthly during the titration phase to monitor side effects such as nausea, constipation, or injection site reactions, with dosage adjustments made according to tolerance and weight loss velocity. The clinic emphasizes that these medications work most effectively when combined with dietary modifications and increased physical activity, though they do not require patients to follow restrictive meal plans.
Patients accessing care through Broward Weight Loss and Primary Care complete their initial paperwork electronically before their first telehealth appointment, which typically lasts 30-45 minutes. During this session, physicians review eligibility criteria including BMI thresholds of 30 kg/m² or 27 kg/m² with weight-related comorbidities, discuss realistic expectations of 10-15% total body weight reduction over 6-12 months, and address insurance coverage or self-pay options for medications. Prescriptions are sent to the patient's preferred pharmacy, with the clinic providing injection technique training via video demonstration for subcutaneous administration. Monthly check-ins allow providers to track progress using patient-reported weight measurements, assess adherence, troubleshoot barriers such as medication side effects or plateau periods, and determine when maintenance dosing has been achieved. The telehealth model proves particularly valuable for patients in Lauderhill, Fort Lauderdale, Plantation, and surrounding Broward County communities who face scheduling constraints or mobility limitations that make regular office visits challenging.
What distinguishes this Lauderhill practice is its integration of weight management within a primary care framework, allowing the same providers to address related metabolic conditions including prediabetes, hypertension, and dyslipidemia that often improve with weight reduction. The clinic's 5.0-star rating across nearly 60 Google reviews reflects consistent feedback about injection guidance, goal achievement support, and responsive communication between appointments. For Florida residents seeking medical supervision for chronic weight management through peptide therapy without the requirement of in-person visits, Broward Weight Loss and Primary Care provides accessible prescribing services with ongoing monitoring to optimize safety and effectiveness throughout the treatment course.
Topics Mentioned in Reviews
Phentermine
It is commonly used as an appetite suppressant to aid in weight loss.
Wegovy (Semaglutide)
This prescription medication has recently been approved by FDA.
Mounjaro (Tirzepatide)
This medication is being developed for the treatment of type 2 diabetes and obesity.
Saxenda
Saxenda is typically used as part of a comprehensive weight management program.
Contrave
Contrave is a prescription medication that is used for weight management in adults who are overweight or have obesity.
Qsymia
Qsymia is a prescription medication that is a combination of two active ingredients: phentermine and topiramate.
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.